BrightAccountsProduction v1.0.0 v1.0.0 2025-01-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The principal activity of the company is the provision of Radiology Services in the Adelaide & Meath Hospital & Euromedic Ireland.

There have been no significant changes in the activities during the year. The director has no plans to change activities & operations of the company for the foreseeable future.
23 June 2026 1 1
NI609398 2025-12-31 NI609398 2024-12-31 NI609398 2023-12-31 NI609398 2025-01-01 2025-12-31 NI609398 2024-01-01 2024-12-31 NI609398 uk-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 NI609398 uk-curr:Euro 2025-01-01 2025-12-31 NI609398 uk-bus:AbridgedAccounts 2025-01-01 2025-12-31 NI609398 uk-bus:Director1 2025-01-01 2025-12-31 NI609398 uk-bus:RegisteredOffice 2025-01-01 2025-12-31 NI609398 uk-bus:Agent1 2025-01-01 2025-12-31 NI609398 uk-core:ShareCapital 2025-12-31 NI609398 uk-core:ShareCapital 2024-12-31 NI609398 uk-core:RetainedEarningsAccumulatedLosses 2025-12-31 NI609398 uk-core:RetainedEarningsAccumulatedLosses 2024-12-31 NI609398 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2025-12-31 NI609398 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2024-12-31 NI609398 uk-core:RetainedEarningsAccumulatedLosses 2025-01-01 2025-12-31 NI609398 uk-bus:FRS102 2025-01-01 2025-12-31 NI609398 uk-core:Goodwill 2025-01-01 2025-12-31 NI609398 uk-core:LandBuildings 2025-01-01 2025-12-31 NI609398 uk-core:Goodwill 2024-12-31 NI609398 uk-core:Goodwill 2025-12-31 NI609398 uk-core:CostValuation 2025-12-31 NI609398 2025-01-01 2025-12-31 NI609398 uk-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 xbrli:pure iso4217:EUR xbrli:shares
Company Registration Number: NI609398
 
 
Feeney Diagnostics Limited
 
Abridged Financial Statements
 
for the financial year ended 31 December 2025
Feeney Diagnostics Limited
DIRECTOR AND OTHER INFORMATION

 
Director John Feeney
 
 
Company Registration Number NI609398
 
 
Registered Office 6B Upper Water Street
Newry
Down
B34 IDJ
Northern Ireland
 
 
Business Address 71 Lombard Street West
South Circular Road
Dublin 8
Republic of Ireland
 
 
Accountants Gary Donnelly & Co Limited
Chartered Accountant
80 Sandford Road
Ranelagh
Dublin 6
Republic of Ireland
 
 
Bankers Bank Of Ireland
  88 Lower Camden Street
  Dublin 2



Feeney Diagnostics Limited
DIRECTOR'S REPORT
for the financial year ended 31 December 2025

 
The director presents their report and the unaudited financial statements for the financial year ended 31 December 2025.
 
Principal Activity

The principal activity of the company is the provision of Radiology Services in the Adelaide & Meath Hospital & Euromedic Ireland.

There have been no significant changes in the activities during the year. The director has no plans to change activities & operations of the company for the foreseeable future.

     
Results and Dividends
The (loss)/profit for the financial year after providing for depreciation and taxation amounted to €(28,546) (2024 - €3,749).
     
Director
The director who served during the financial year is as follows:
     
John Feeney
   
There were no changes in shareholdings between 31 December 2025 and the date of signing the financial statements.
     
In accordance with the Articles of Association, the directors retire by rotation and, being eligible, offer themselves for re-election.
     
Charitable and political contributions
The company did not make any disclosable political donations in the current financial year.
     
Statement of Director's Responsibilities
     
The director is responsible for preparing the Director's Report and the financial statements in accordance with applicable law and regulations.
     

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland". Under company law the director must not approve the financial statements unless they is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the director is required to:

- select suitable accounting policies and apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
     
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
     
Special provisions relating to small companies
The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.
     
     
On behalf of the board
     
     
___________________________
John Feeney
Director
     
23 June 2026



Feeney Diagnostics Limited
ABRIDGED PROFIT AND LOSS ACCOUNT
for the financial year ended 31 December 2025
2025 2024
Notes

Gross profit 92,705 127,073
 
Administrative expenses (121,251) (121,139)
───────── ─────────
(Loss)/profit before taxation (28,546) 5,934
 
Tax on (loss)/profit - (2,185)
───────── ─────────
(Loss)/profit for the financial year (28,546) 3,749
───────── ─────────
Total comprehensive income (28,546) 3,749
    ═════════   ═════════



Feeney Diagnostics Limited
Company Registration Number: NI609398
ABRIDGED BALANCE SHEET
as at 31 December 2025

2025 2024
Notes
 
Fixed Assets
Tangible assets 68,250 79,625
Investments 5 100,000 100,000
───────── ─────────
Fixed Assets 168,250 179,625
───────── ─────────
 
Current Assets
Debtors 81,266 91,114
Cash and cash equivalents 490,572 497,573
───────── ─────────
571,838 588,687
───────── ─────────
Creditors: amounts falling due within one year (93,711) (93,389)
───────── ─────────
Net Current Assets 478,127 495,298
───────── ─────────
Total Assets less Current Liabilities 646,377 674,923
═════════ ═════════
 
Capital and Reserves
Called up share capital 1 1
Retained earnings 646,376 674,922
───────── ─────────
Equity attributable to owners of the company 646,377 674,923
═════════ ═════════
 
These abridged financial statements have been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.
           
All of the members have consented to the preparation of abridged accounts in accordance with section 444(2A) of the Companies Act 2006.
For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
           
The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
           
The director acknowledges their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
           
Approved by the Director and authorised for issue on 23 June 2026
           
           
________________________________          
John Feeney          
Director          
           



Feeney Diagnostics Limited
RECONCILIATION OF SHAREHOLDERS' FUNDS
as at 31 December 2025

Called up Retained Total
share earnings
capital
 
At 1 January 2024 1 671,173 671,174
───────── ───────── ─────────
Profit for the financial year - 3,749 3,749
───────── ───────── ─────────
At 31 December 2024 1 674,922 674,923
  ───────── ───────── ─────────
Loss for the financial year - (28,546) (28,546)
  ───────── ───────── ─────────
At 31 December 2025 1 646,376 646,377
  ═════════ ═════════ ═════════



Feeney Diagnostics Limited
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
for the financial year ended 31 December 2025

   
1. General Information
 
Feeney Diagnostics Limited is a company limited by shares incorporated in the Northern Ireland
         
2. Summary of Significant Accounting Policies
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the year ended 31 December 2025 have been prepared in accordance with the Financial Reporting Standard applicable in the United Kingdom and the Republic of Ireland (FRS 102) issued by the Financial Reporting Council and in accordance with the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
 
Cash flow statement
The company has availed of the exemption in FRS 102 from the requirement to prepare a Cash Flow Statement because it is classified as a small company.
 
Turnover
Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.
 
Goodwill
Purchased goodwill arising on the acquisition of a business represents the excess of the acquisition cost over the fair value of the identifiable net assets including other intangible fixed assets when they were acquired. Purchased goodwill is capitalised in the Balance Sheet and amortised on a straight line basis over its economic useful life of Acquired goodwill is capitalised and classified as an asset on the balance sheet, internally generated goodwill is not capitalised.  Goodwill is written off in equal annual instalments over its estimated useful economic life of (enter number of years).  Goodwill is reviewed for impairment at the end of the first full financial year following each acquisition and subsequently as and when necessary if circumstances emerge that indicate that the carrying value may not be recoverable. years, which is estimated to be the period during which benefits are expected to arise.  On disposal of a business any goodwill not yet amortised is included in determining the profit or loss on sale of the business.
 
Tangible assets and depreciation
Tangible assets are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of tangible assets, less their estimated residual value, over their expected useful lives as follows:
 
  Land and buildings freehold - 4% Straight line
 
The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
 
Investments
Investments held as fixed assets are stated at cost less provision for any permanent diminution in value. Income from other investments together with any related tax credit is recognised in the Profit and Loss Account in the year in which it is receivable.
 
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Employee benefits
The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The company also operates a defined benefit pension scheme for its employees providing benefits based on final pensionable pay. The assets of this scheme are also held separately from those of the company, being invested with pension fund managers.
 
Taxation
Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.
 
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Balance Sheet date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Profit and Loss Account.
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
       
3. Employees
 
The average monthly number of employees, including director, during the financial year was 0.00|0, (2024 - 1).
 
  2025 2024
  Number Number
 
Class S - Director 1 1
  ═════════ ═════════
       
4. Intangible assets
     
  Goodwill Total
 
Cost
At 1 January 2025 175,000 175,000
  ───────── ─────────
 
At 31 December 2025 175,000 175,000
  ───────── ─────────
Amortisation
At 1 January 2025 175,000 175,000
  ───────── ─────────
 
At 31 December 2025 175,000 175,000
  ───────── ─────────
Net book value
At 31 December 2025 - -
  ═════════ ═════════
At 31 December 2024 - -
  ═════════ ═════════
       
5. Investments
  Other Total
  investments  
     
Investments
Cost
 
At 31 December 2025 100,000 100,000
  ───────── ─────────
Net book value
At 31 December 2025 100,000 100,000
  ═════════ ═════════
At 31 December 2024 100,000 100,000
  ═════════ ═════════